Renan Rosa

Renan Rosa is the Country Lead for the Brazil affiliate of Alnylam Pharmaceuticals, overseeing operations in Latin America since February 2022. Previously, Renan served as the Senior Director of Commercial Excellence for Partner and Emerging Markets at Biogen and held various roles at Gilead Sciences, including Business Unit Director for Aducanumab/Alzheimer and Director of Strategic Planning for Latin America. Renan's extensive experience includes managing HCV franchise strategies, developing regulatory and pricing strategies, and leading marketing and sales operations for hepatitis C treatments across multiple companies, including Boehringer Ingelheim and MSD. Renan’s educational background comprises a Bachelor's degree in Business from Universidade Presbiteriana Mackenzie and Executive education in Marketing from Northwestern University's Kellogg School of Management.